Details
Open$0.20
$0.20
The price of this investment when the exchange last opened.
High$0.20
$0.20
The highest price of this investment during regular trading hours.
Low$0.19
$0.19
The lowest price of this investment during regular trading hours.
Mkt cap42M
42M
The value of this ETF or company's issued shares based on the price of a single share multiplied by the total number of issued shares.
P/E ratio
The price to earnings ratio (P/E) is the relationship between an investment's price and earnings per share (EPS). It's a metric that can be used to determine the valuation or potential growth of an investment based on its past or future earnings. It's calculated by dividing the share price by EPS.
52-wk high$2.65
$2.65
The highest price this investment has been in the past 52 weeks.
52-wk low$0.12
$0.12
The lowest price this investment has been in the past 52 weeks.
Volume661K
661K
The total number of shares bought and sold.
EPS (TTM)-0.73
-0.73
Earnings per share (EPS) is the amount of profit a company generated for each outstanding share of its common stock. It is often used as an indicator of company profitability.
About EMH
Emerald Health Therapeutics, Inc. is a pharmaceutical company, which engages in the production and sale of cannabis products. Its products include dried cannabis and cannabis oil, pants and seeds. The company was founded on Jul 31, 2007 and is headquartered in Vancouver, Canada.
CEO
Riaz Amirali Bandali, MBA
Headquarters
Canada
Employees
179
Revenue (TTM)
21.1M
Gross Profit
-413.57%
Earnings
-248.17%
Cash
$581K
Debt
$28M
